Jazz Pharmaceuticals PLC (JAZZ)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	560,120	463,159	394,924	330,794	414,832	80,727	-83,196	-152,969	-216,600	-12,000	-47,730	-445,711	-329,668	-160,903	40,164	518,281	238,616	179,194	133,236	280,333
Total assets	US$ in thousands	12,012,300	12,255,700	11,361,900	11,327,100	11,393,400	11,204,100	11,260,500	11,047,100	10,835,300	10,384,700	11,200,100	11,768,900	12,298,600	12,478,200	13,213,000	6,756,470	6,535,900	6,291,960	6,066,500	5,215,300
ROA		4.66%	3.78%	3.48%	2.92%	3.64%	0.72%	-0.74%	-1.38%	-2.00%	-0.12%	-0.43%	-3.79%	-2.68%	-1.29%	0.30%	7.67%	3.65%	2.85%	2.20%	5.38%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $560,120K ÷ $12,012,300K
= 4.66%

The return on assets (ROA) for Jazz Pharmaceuticals PLC has shown fluctuating trends over the past few years. From March 31, 2020, to December 31, 2020, the ROA ranged between 2.20% and 5.38%. There was a significant increase in ROA to 7.67% by March 31, 2021, followed by a sharp decline to 0.30% by June 30, 2021.

Subsequently, the ROA turned negative from September 30, 2021, to June 30, 2022, indicating that the company's assets were not generating a positive return during this period. However, from December 31, 2022, onwards, the ROA started to improve, reaching 4.66% by December 31, 2024.

Overall, the ROA performance of Jazz Pharmaceuticals PLC reflects both periods of profitability and inefficiency in generating earnings from its assets. Investors and stakeholders should monitor this metric closely to assess the company's efficiency in utilizing its assets to generate profits.